Structure, binding interface and hydrophobic transitions of Ca 2+-loaded calbindin-D28K

Nature Structural and Molecular Biology

Volumn 13, Issue 7, 2006, Pages 641-647

  Kojetin, Douglas J ^a   Venters, Ronald A ^b   Kordys, David R ^a   Thompson, Richele J ^a   Kumar, Rajiv ^c   Cavanagh, John ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CALBINDIN; CALCIUM ION; INOSITOL PHOSPHATASE; PHOSPHATASE; RAN BINDING PROTEIN M; UNCLASSIFIED DRUG;

ARTICLE; HYDROPHOBICITY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SPECTROFLUOROMETRY;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CALCIUM; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CLONING, MOLECULAR; HYDROGEN BONDING; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; PEPTIDES; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; RATS; RECOMBINANT PROTEINS;

EID: 33745813182     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb1112     Document Type: Article

References (59)

1. Gross, M. & Kumar, R. Physiology and biochemistry of vitamin D-dependent calcium binding proteins. Am. J. Physiol. 259, F195-F209 (1990).
2. Oberholtzer, J.C., Buettger, C., Summers, M.C. & Matschinsky, F.M. The 28-kDa calbindin-D is a major calcium-binding protein in the basilar papilla of the chick. Proc. Natl. Acad. Sci. USA 85, 3387-3390 (1988).
3. Lutz, W. et al. Calbindin D28K interacts with Ran-binding protein M: identification of interacting domains by NMR spectroscopy. Biochem. Biophys. Res. Commun. 303, 1186-1192 (2003).
4. 28K. J. Biol. Chem. 277, 41954-41959 (2002).
5. Christakos, S. & Liu, Y. Biological actions and mechanism of action of calbindin in the process of apoptosis. J. Steroid Biochem. Mol. Biol. 89-90, 401-404 (2004).
6. 28K. Protein Sci. 9, 2094-2108 (2000).
7. 28K as determined from the association of six synthetic EF-hand fragments. Protein Sci. 6, 2385-2396 (1997).
8. 28K is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity. J. Biol. Chem. 275, 26328-26332 (2000).
9. 28K in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology 142, 3649-3655 (2001).
10. 28K. J. Bone Miner. Res. 19, 479-490 (2004).
11. Christakos, S. et al. Vitamin D target proteins: function and regulation. J. Cell. Biochem. 88, 238-244 (2003).
12. 28K and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder. Bipolar Disord. 7, 42-48 (2005).
13. 28K targets myo-inositol monophosphatase in spines and dendrites of cerebellar Purkinje neurons. Proc. Natl. Acad. Sci. USA 102, 5850-5855 (2005).
14. 28K: a nuclear magnetic resonance and microelectrospray mass spectrometry study. Anal. Biochem. 317, 59-66 (2003).
15. 28K). Biochem. Biophys. Res. Commun. 138, 547-553 (1986).
16. 28K, the vitamin D-dependent 28 kDa calcium binding protein. FEBS Lett. 297, 127-131 (1992).
17. Ikura, M. Calcium binding and conformational response in EF-hand proteins. Trends Biochem. Sci. 21, 14-17 (1996).
18. Nakamura, M. et al. When overexpressed, a novel centrosomal protein, RanBPM, causes ectopic microtubule nucleation similar to gamma-tubulin. J. Cell Biol. 143, 1041-1052 (1998).
19. Nishimoto, T. A new role of ran GTPase. Biochem. Biophys. Res. Commun. 262, 571-574 (1999).
20. Nishitani, H. et al. Full-sized RanBPM cDNA encodes a protein possessing a long stretch of proline and glutamine within the N-terminal region, comprising a large protein complex. Gene 272, 25-33 (2001).
21. Rao, M.A. et al. RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor. J. Biol. Chem. 277, 48020-48027 (2002).
22. Seki, T., Hayashi, N. & Nishimoto, T. RCC1 in the Ran pathway. J. Biochem. 120, 207-214 (1996).
23. Moore, M.S. Generation of GTP-Ran for nuclear protein import. Science 272, 47 (1996).
24. Cotman, C.W., Poon, W.W., Rissman, R.A. & Blurton-Jones, M. The role of caspase cleavage of tau in Alzheimer disease neuropathology. J. Neuropathol. Exp. Neurol. 64, 104-112 (2005).
25. Hodges, A. et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 15, 965-977 (2006).
26. Wellington, C.L. et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275, 19831-19838 (2000).
27. Yuan, J. & Yankner, B.A. Apoptosis in the nervous system. Nature 407, 802-809 (2000).
28. Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429, 883-891 (2004).
29. Colin, E. et al. Akt is altered in an animal model of Huntington's disease and in patients. Eur. J. Neurosci. 21, 1478-1488 (2005).
30. 28K. Biochemistry 39, 6864-6873 (2000).
31. 28K EF-hand ligand binding and oligomerization: four high-affinity sites-three modes of action. Biochemistry 44, 13522-13532 (2005).
32. 2+ sensor. J. Biol. Chem. 277, 16662-16672 (2002).
33. 28K by electrospray ionization mass spectrometry. Biochemistry 36, 3535-3542 (1997).
34. 28K with effects on calcium binding. Protein Sci. 14, 968-979 (2005).
35. 28K are structurally and functionally important. Biochemistry 44, 684-693 (2005).
36. Johnson, K.L. et al. On-line sample clean-up and chromatography coupled with electrospray ionization mass spectrometry to characterize the primary sequence and disulfide bond content of recombinant calcium binding proteins. Biomed. Chromatogr. 13, 37-45 (1999).
37. 28K from human brain. Biochemistry 41, 6185-6192 (2002).
38. 2+ binding. Biometals 11, 297-318 (1998).
39. 28K (1-93). Eur. J. Biochem. 262, 933-938 (1999).
40. Mueller, G.A. et al. Global folds of proteins with low densities of NOEs using residual dipolar couplings: application to the 370-residue maltodextrin-binding protein. J. Mol. Biol. 300, 197-212 (2000).
41. Atreya, H.S. & Chary, K.V.R. New chemical shift signatures of bound calcium in EF-hand proteins. Curr. Sci. [online] 83, 1240-1245 (2002).
42. 2+ binding to EF-hand proteins. Biochemistry 43, 6554-6564 (2004).
43. Linge, J.P., Williams, M.A., Spronk, C.A., Bonvin, A.M. & Nilges, M. Refinement of protein structures in explicit solvent. Proteins 50, 496-506 (2003).
44. Rigden, D.J. & Galperin, M.Y. The DxDxDG motif for calcium binding: multiple structural contexts and implications for evolution. J. Mol. Biol. 343, 971-984 (2004).
45. 28K as assessed by spectroscopic analyses of synthetic peptide fragments. Biochemistry 35, 3662-3669 (1996).
46. Donepudi, M. & Grutter, M.G. Structure and zymogen activation of caspases. Biophys. Chem. 101-102, 145-153 (2002).
47. Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293 (1995).
48. Johnson, B.A. & Blevins, R.A. NMRView - a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4, 603-614 (1994).
49. 28K. J. Biomol. NMR 28, 305-306 (2004).
50. Cornilescu, G., Delaglio, F. & Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289-302 (1999).
51. 2H-labeled proteins. J. Biomol. NMR 14, 333-343 (1999).
52. NC, connectivities across hydrogen bonds in a 30 kDa protein. J. Biomol. NMR 14, 181-184 (1999).
53. Brunger, A.T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905-921 (1998).
54. Stein, E.G., Rice, L.M. & Brunger, A.T. Torsion-angle molecular dynamics as a new efficient tool for NMR structure calculation. J. Magn. Reson. 124, 154-164 (1997).
55. Choy, W.Y., Tollinger, M., Mueller, G.A. & Kay, L.E. Direct structure refinement of high molecular weight proteins against residual dipolar couplings and carbonyl chemical shift changes upon alignment: an application to maltose binding protein. J. Biomol. NMR 21, 31-40 (2001).
56. Nabuurs, S.B. et al. Quantitative evaluation of experimental NMR restraints. J. Am. Chem. Soc. 125, 12026-12034 (2003).
57. Laskowski, R.A., Rullmannn, J.A., MacArthur, M.W., Kaptein, R. & Thornton, J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477-486 (1996).
58. Davis, I.W., Murray, L.W., Richardson, J.S. & Richardson, D.C. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res. 32, W615-W619 (2004).
59. Gouet, P., Robert, X. & Courcelle, E. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res. 31, 3320-3323 (2003).